Grupo 1
Fisiopatología e Investigación Clínica de las Enfermedades de Base Inmunológica e Inflamatoria Crónicas
- Director/a
- Paloma Sánchez-Mateos Rubio
- Tipo de grupo
- CONSOLIDADO
- Líneas de investigación
-
Axis 1. Immunotherapy with immunomodulatory agents in immunomediated pathologies.
L1: Immunomodulation of innate, adaptive and genetic responses with immunomodulatory agents in the treatment of immune-mediated diseases.
Axis 2. Study of immunopathogenic mechanisms in: (2.1) Primary Immunodeficiencies and (2.2) Secondary to emerging virus infections (SARS-CoV2); (2.4) Immuno-oncology; (2.7) Autoimmune Chronic Inflammatory Diseases; (2.9) Reproductive Failures and (2.10) Solid Organ Transplantation.
L1: Primary immunodeficiencies: immunopathogenesis, classification and treatment.
L2: Study of specific memory T-cell responses to SARS-CoV2.
L3: Biomarkers in secondary immunodeficiencies.
L4: Cell migration in cancer.
L5: Tumour macrophages in melanoma
L6: Study of the efficacy of combining immunotherapy and radiotherapy in different human tumours.
L7: Immunology of autoimmune chronic inflammatory diseases.
L8: Role of macrophages in Autoimmune Inflammatory Diseases
L9: Reproductive Immunology
L10: Transplantation Immunology
Axis 3: Immunology and HLA; Population Genetics and Signal Transduction
L1: Immunology and HLA
L2: Population genetics
L3: Signal transduction